Abstract
Ursane and lupane type (1-((5-aryl-1,3,4-oxadiazol-2-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl and (1-((4-methyl-2-oxido-1,2,5-oxadiazol-3-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl hybrids were prepared by 1,3-cycloaddition reactions of azole-derived azides with alkyne esters connected to positions C-3 and C-28 of triterpene core and tested for cytotoxicity. Hybrid compounds of 1,3,4-oxadiazoles attached at positions 3- and 28- of triterpenoid frame via triazole spacer and combinations of 1,2,5-oxadiazole or 1,3,4-oxadiazole, tethered with succinate linker and 1,2,3-triazole at the position 3- of the ursane backbone, were inactive in relation to all the cancer cells tested. Eventually, combinations of furoxan fragment and 1,2,3-triazole linked to C-28 position of triterpene backbone demonstrated marked cytotoxic activity towards MCF-7 and HepG2 cells. The most active ester of ursolic acid with (1-((4-methyl-2-oxido-1,2,5-oxadiazol-3-yl)methyl)-1H-1,2,3-triazol-4-yl)methyl substituent and 3-O-acetyl group was superior in activity and selectivity over doxorubicin and ursolic acid on MCF-7 cells. The length of the carbon spacer group may be of crucial importance for cytotoxicity. The introduction of the additional ester linker between...Continue Reading
References
Jun 26, 1992·Cell·J MomandA J Levine
Dec 16, 1983·Journal of Immunological Methods·T Mosmann
Jan 24, 2002·Journal of Agricultural and Food Chemistry·Shengmin SangChi-Tang Ho
Oct 13, 2006·Journal of Medicinal Chemistry·Richard A FriesnerDaniel T Mainz
Sep 11, 2009·Planta medica·Melanie N Laszczyk
Sep 18, 2009·Bioorganic & Medicinal Chemistry·Huang-Yao TuChun-Nan Lin
Feb 24, 2011·European Journal of Medicinal Chemistry·V PadmavathiK Mahesh
Mar 25, 2011·Current Medicinal Chemistry·M Decker
Feb 16, 2012·Bioorganicheskaia khimiia·Eun Ha LeeSang Hoon Jung
Mar 13, 2012·Cancer Letters·Muthu K ShanmugamGautam Sethi
Sep 25, 2012·Bioorganicheskaia khimiia·Chan Woo LeeS A Popov
Jul 3, 2013·European Journal of Medicinal Chemistry·Showkat RashidBilal Ahmad Bhat
Dec 3, 2014·Bioorganic & Medicinal Chemistry Letters·Tuyet Anh Dang ThiTuyen Van Nguyen
Dec 6, 2014·Organic & Biomolecular Chemistry·Gaofei WeiMaosheng Cheng
Jan 27, 2015·European Journal of Medicinal Chemistry·Haijun ChenJia Zhou
Apr 5, 2015·European Journal of Medicinal Chemistry·Shi-Xian HuaHeng-Shan Wang
Jun 2, 2015·Natural Product Reports·Miroslav KvasnicaJan Sarek
Nov 20, 2015·Journal of Chemical Theory and Computation·Edward HarderRichard A Friesner
Jan 19, 2016·Life Sciences·Dharambir KashyapAnil K Sharma
May 19, 2016·European Journal of Medicinal Chemistry·Nisar A DangrooPayare L Sangwan
Jun 28, 2016·Molecular Biology Reports·Balraj Singh Gill Navgeet
Aug 27, 2016·Pharmaceutical Biology·Qiuxia HuangXing Zheng
Oct 21, 2016·Journal of Asian Natural Products Research·Banita PattnaikUppuluri V Mallavadhani
Apr 25, 2017·Steroids·Nisar A DangrooPayare L Sangwan
Jun 24, 2017·Expert Opinion on Therapeutic Patents·Hidayat HussainIshtiaq Ahmed
Jul 30, 2017·European Journal of Medicinal Chemistry·Jorge A R SalvadorVanessa I S Mendes
Aug 13, 2017·Molecular Nutrition & Food Research·Xiaoyao MaGang Bai
Apr 18, 2018·Mini Reviews in Medicinal Chemistry·Rajan SharmaSarel F Malan
Apr 22, 2018·Bioorganic & Medicinal Chemistry Letters·Zhi-Yu WeiHu-Ri Piao
May 16, 2018·Carcinogenesis·Wei WangRuiwen Zhang
Oct 16, 2018·Genes & Diseases·Jiang-Jiang QinRuiwen Zhang
Feb 5, 2019·The FEBS Journal·Lukasz SkalniakTad A Holak
Feb 26, 2019·Bioorganic & Medicinal Chemistry Letters·René Csuk, Hans-Peter Deigner
Jul 12, 2019·Steroids·Sergey A PopovMāris Turks